Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 123

1.

Pharmacologic treatment of opioid-induced constipation.

Wang CZ, Yuan CS.

Expert Opin Investig Drugs. 2013 Oct;22(10):1225-7. doi: 10.1517/13543784.2013.819341. Epub 2013 Jul 9.

PMID:
23834367
[PubMed - indexed for MEDLINE]
2.

Treatment of opioid-induced constipation: focus on the peripheral μ-opioid receptor antagonist methylnaltrexone.

Rauck RL.

Drugs. 2013 Aug;73(12):1297-306. doi: 10.1007/s40265-013-0084-5. Review.

PMID:
23881667
[PubMed - indexed for MEDLINE]
3.

Clinical status of methylnaltrexone, a new agent to prevent and manage opioid-induced side effects.

Yuan CS.

J Support Oncol. 2004 Mar-Apr;2(2):111-7; discussion 119-22. Review.

PMID:
15328815
[PubMed - indexed for MEDLINE]
4.

The role of opioid receptor antagonists in the treatment of opioid-induced constipation: a review.

Leppert W.

Adv Ther. 2010 Oct;27(10):714-30. doi: 10.1007/s12325-010-0063-0. Epub 2010 Aug 26. Review.

PMID:
20799006
[PubMed - indexed for MEDLINE]
5.

Methylnaltrexone: MNTX.

[No authors listed]

Drugs R D. 2006;7(6):374-8. Review.

PMID:
17073520
[PubMed - indexed for MEDLINE]
6.

Methylnaltrexone for opioid-induced constipation in patients with advanced illness: a 3-month open-label treatment extension study.

Lipman AG, Karver S, Cooney GA, Stambler N, Israel RJ.

J Pain Palliat Care Pharmacother. 2011;25(2):136-45. doi: 10.3109/15360288.2011.573531.

PMID:
21657861
[PubMed - indexed for MEDLINE]
7.

Methylnaltrexone: treatment for opioid-induced constipation.

Licup N, Baumrucker SJ.

Am J Hosp Palliat Care. 2011 Feb;28(1):59-61. doi: 10.1177/1049909110373507. Epub 2010 Aug 27. Review.

PMID:
20801917
[PubMed - indexed for MEDLINE]
8.

Methylnaltrexone: a novel approach for the management of opioid-induced constipation in patients with advanced illness.

Diego L, Atayee R, Helmons P, von Gunten CF.

Expert Rev Gastroenterol Hepatol. 2009 Oct;3(5):473-85. doi: 10.1586/egh.09.42. Review.

PMID:
19817669
[PubMed - indexed for MEDLINE]
9.

Relistor approved for opioid-related constipation.

Traynor K.

Am J Health Syst Pharm. 2008 Jun 1;65(11):996. doi: 10.2146/news080043. No abstract available.

PMID:
18499867
[PubMed - indexed for MEDLINE]
10.

Methylnaltrexone bromide: research update of pharmacokinetics following parenteral administration.

Rotshteyn Y, Boyd TA, Yuan CS.

Expert Opin Drug Metab Toxicol. 2011 Feb;7(2):227-35. doi: 10.1517/17425255.2011.549824. Epub 2011 Jan 11. Review.

PMID:
21222554
[PubMed - indexed for MEDLINE]
11.

Subcutaneous methylnaltrexone for treatment of opioid-induced constipation in patients with chronic, nonmalignant pain: a randomized controlled study.

Michna E, Blonsky ER, Schulman S, Tzanis E, Manley A, Zhang H, Iyer S, Randazzo B.

J Pain. 2011 May;12(5):554-62. doi: 10.1016/j.jpain.2010.11.008. Epub 2011 Mar 22.

PMID:
21429809
[PubMed - indexed for MEDLINE]
12.

A review of the potential role of methylnaltrexone in opioid bowel dysfunction.

Foss JF.

Am J Surg. 2001 Nov;182(5A Suppl):19S-26S. Review.

PMID:
11755893
[PubMed - indexed for MEDLINE]
13.
14.

Methylnaltrexone treatment of opioid-induced constipation in patients with advanced illness.

Chamberlain BH, Cross K, Winston JL, Thomas J, Wang W, Su C, Israel RJ.

J Pain Symptom Manage. 2009 Nov;38(5):683-90. doi: 10.1016/j.jpainsymman.2009.02.234. Epub 2009 Aug 26.

PMID:
19713070
[PubMed - indexed for MEDLINE]
15.

Efficacy of subcutaneous methylnaltrexone in the treatment of opioid-induced constipation: a responder post hoc analysis.

Michna E, Weil AJ, Duerden M, Schulman S, Wang W, Tzanis E, Zhang H, Yu D, Manley A, Randazzo B.

Pain Med. 2011 Aug;12(8):1223-30. doi: 10.1111/j.1526-4637.2011.01189.x. Epub 2011 Aug 2.

PMID:
21810165
[PubMed - indexed for MEDLINE]
16.

Methylnaltrexone for the treatment of opioid-induced constipation.

Bader S, Dürk T, Becker G.

Expert Rev Gastroenterol Hepatol. 2013 Jan;7(1):13-26. doi: 10.1586/egh.12.63. Review.

PMID:
23265145
[PubMed - indexed for MEDLINE]
17.

Management of opioid-induced constipation in cancer patients: focus on methylnaltrexone.

Gatti A, Sabato AF.

Clin Drug Investig. 2012 May 1;32(5):293-301. doi: 10.2165/11598000-000000000-00000. Review.

PMID:
22413747
[PubMed - indexed for MEDLINE]
18.

Effect of subcutaneous methylnaltrexone on patient-reported constipation symptoms.

Iyer SS, Randazzo BP, Tzanis EL, Schulman SL, Zhang H, Wang W, Manley AL.

Value Health. 2011 Jan;14(1):177-83. doi: 10.1016/j.jval.2010.11.003.

PMID:
21211500
[PubMed - indexed for MEDLINE]
19.

Methylnaltrexone for opioid-induced constipation in advanced illness.

Thomas J, Karver S, Cooney GA, Chamberlain BH, Watt CK, Slatkin NE, Stambler N, Kremer AB, Israel RJ.

N Engl J Med. 2008 May 29;358(22):2332-43. doi: 10.1056/NEJMoa0707377.

PMID:
18509120
[PubMed - indexed for MEDLINE]
Free Article
20.

Methylnaltrexone: new drug. Opiate-induced constipation: barely more effective than placebo.

[No authors listed]

Prescrire Int. 2009 Aug;18(102):158. No abstract available.

PMID:
19743572
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk